{
  "id": "e75e926650d42467",
  "title": "STAT+: BioMarin CEO says $4.8 billion Amicus deal will lead to cost savings and revenue growth",
  "description": "BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.",
  "content": "BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/19/biomarin-ceo-deal-with-amicus-rare-disease/?utm_campaign=rss",
  "published_at": "2025-12-19T16:35:06+00:00",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: BioMarin CEO says $4.8 billion Amicus deal will lead to cost savings and revenue growth",
    "description": "BioMarin's new CEO had promised Wall Street there would be deals, and with Amicus, it has one the market likes.",
    "url": "https://www.statnews.com/2025/12/19/biomarin-ceo-deal-with-amicus-rare-disease/?utm_campaign=rss",
    "published": "2025-12-19T16:35:06+00:00",
    "source": "STAT"
  }
}